Inventor
BELARDI JUSTIN K
US12 patents
⚠️ This page may combine multiple inventors who share the name “BELARDI JUSTIN K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KNOPP BIOSCIENCES LLC
9 patentsUS9914708B2Mar 13, 2018
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC10 citations92
US9481653B2Nov 1, 2016
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC15 citations92
US11724990B2Aug 15, 2023
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC4 citations85
US10851067B2Dec 1, 2020
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC6 citations83
US10385025B2Aug 20, 2019
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC9 citations83
US9650376B2May 16, 2017
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
KNOPP BIOSCIENCES LLC8 citations81
US11261162B2Mar 1, 2022
KV7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC3 citations72
US10906877B2Feb 2, 2021
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC1 citations72
US10526328B2Jan 7, 2020
Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC0 citations51
BIOHAVEN THERAPEUTICS LTD
3 patentsUS12351559B2Jul 8, 2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators
BIOHAVEN THERAPEUTICS LTD0 citations62
US12286408B2Apr 29, 2025
KV7 channel activators compositions and methods of use
BIOHAVEN THERAPEUTICS LTD0 citations62
US11834418B2Dec 5, 2023
Benzoimidazol-1,2-yl amides as Kv7 channel activators
BIOHAVEN THERAPEUTICS LTD0 citations62